TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Tataa Biocenter AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
52,839
|
34,738
|
91,877 |
Financial expenses |
7
|
340
|
3 |
Earnings before taxes |
-61,144
|
-57,234
|
-10,623 |
EBITDA |
-55,233
|
-51,543
|
4,075 |
Total assets |
44,370
|
41,941
|
67,354 |
Current assets |
27,131
|
21,441
|
42,791 |
Current liabilities |
14,481
|
25,162
|
41,708 |
Equity capital |
29,888
|
16,779
|
25,645 |
- share capital |
141
|
131
|
136 |
Employees (average) |
46
|
47
|
41 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
67.4%
|
40.0%
|
38.1% |
Turnover per employee |
1,149
|
739
|
2,241 |
Profit as a percentage of turnover |
-115.7%
|
-164.8%
|
-11.6% |
Return on assets (ROA) |
-137.8%
|
-135.7%
|
-15.8% |
Current ratio |
187.4%
|
85.2%
|
102.6% |
Return on equity (ROE) |
-204.6%
|
-341.1%
|
-41.4% |
Change turnover |
15,636
|
-54,378
|
13,171 |
Change turnover % |
42%
|
-61%
|
17% |
Chg. No. of employees |
-1
|
6
|
13 |
Chg. No. of employees % |
-2%
|
15%
|
46% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.